Definitive Contract 00266200007D266005418
Award Date
7/27/00
Potential Completion Date
11/30/06
Potential Value
$7.3M
Federal Agency
NIAID DEA OA Acquisitions
Awardee
J.david Gladstone Institutes
Ultimate Awardee
Not listed
NAICS Category
Not listed
PSC Category
AN81 - R&D- Medical: Aids Research (Basic Research)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
West Menlo Park, CA 94025, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute on Aging (NIA) awarded a $200,000.00 firm-fixed price purchase order contract to the J. David Gladstone Institutes, a non-profit biomedical research organization located in San Francisco, California. The contract, which has no set-aside designation, is for the provision of research-related goods and services in support of the NIA's mission. The J. David Gladstone Institutes has a history of federal contract and grant awards, having previously conducted research for...
This is a definitive, cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services' National Institutes of Health (NIH), to Diadexus, Inc., a for-profit manufacturer, for AIDS research activities. The contract has a potential value of $80,286,861.00 and a completion date of April 3, 2007. The contract was awarded on September 30, 2003 and does not have a set-aside designation. The place of...
This is a $12,436,225.00 Cost Plus Fixed Fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to BBI Biotech Research Laboratories Incorporated on June 30, 1998 for AIDS research (basic). The contract has an ultimate completion date of December 31, 2007 and was not set aside for any special designation. As NIAID is the research arm of the National Institutes of Health focused on infectious diseases, this contract is likely...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS). The $128,312.76 cost-plus-fixed-fee contract was awarded to Southern Research Institute, a non-profit organization that provides research and development services, to develop new assays for HIV therapeutics and topical microbicides. The contract does not have a set-aside designation. Southern Research Institute...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization. The $257,889.11 cost-plus-fixed-fee contract is for the identification of anti-HIV lead compounds, which is part of NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract has no set-aside designation and is a...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government, to the Institute for Defense Analyses (IDA), a nonprofit organization that operates Federally Funded Research and Development Centers (FFRDCs). The contract, valued at $80,237.08, is for AIDS research management and support services. It is a delivery order contract with a cost-plus-fixed-fee pricing type, without any set-aside designation....
This is a Cost Plus Fixed Fee federal delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization. The $249,997 contract is for the identification of anti-HIV lead compounds as part of NIAID's in vitro testing resource for HIV therapeutics and topical microbicides. Southern Research Institute, which holds multiple federal indefinite...
This federal contract award, valued at $499,879.67, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit research organization. The contract is for the identification of lead compounds to inhibit HIV, as part of NIAID's broader "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract is a Delivery Order...
This is a $544,000.00 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to Southern Research Institute, a corporate entity tax-exempt non-profit organization. The contract is for biomedical (applied/exploratory) research and does not have a set-aside designation. Through this contract, Southern Research Institute is providing a range of services, including drug discovery and...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The $254,076.51 cost-plus-fixed-fee delivery order contract was awarded to Southern Research Institute, a non-profit organization that provides advanced drug discovery and development services. The contract supports high-throughput screening to identify HIV inhibitors as part of NIAID's "In Vitro Testing...